← Back to all development cases
This case was judged by an anonymized AI reviewer and has not been independently reviewed by people; inspect the draft, cards, and both outputs to assess it.
AutocompleteWithout cards better11 / 280 · beu-77d4bcceaac1b33e

Large Language Models in Bioinformatics: A Survey

Quantitative biology · 2503.04490v3

FLOWING EVIDENCE BENCHMARK

How do we compare writing with and without cards?

At the same writing position, the same model produces one first result with cards and one without. All 280 pairs enter the overall anonymized review, which assesses whether a decision not to continue fits the draft.

Overall: 138 with-card wins, 26 ties, 107 no-card wins, 5 pairs where neither was usable, and 4 inconclusive judgments. Both sides wrote text in 218 pairs; 48 had a deliberate stop and 14 included an invalid output.

SAME DRAFT · WITH OR WITHOUT CARDS

01 · FIXED WRITING POSITION

MANUSCRIPT

Same writing position ▌

Matched autocomplete at the same draft position

02 · TWO MATCHED VERSIONS

SHARED BY BOTH

Draft, writing task, and generation model

A · With cards

Relevant literature cards supplied

B · Without cards

No literature cards supplied

Generation model

Same model and version

A → first output

B → first output

Anonymized AI judge

First outputs are anonymized as X and Y

Continuation review: accuracy, fit to the writing task and usability
Returns: X preferred / tie / Y preferred / both unusable

Review again with the answer order swapped

HOW DOES BLIND JUDGING WORK?

① Anonymize both outputs
The AI judge sees the same draft and both first outputs without knowing which received cards.

② Compare and swap order
The judge applies task-specific criteria in X/Y and then Y/X order.

③ Review disagreements
A third pass resolves disagreements. Incomplete reviews remain in the denominator.

How are positions and cards selected?

We selected 40 writing positions in each of seven fields, for 280 comparisons. The position and relevant literature cards were set before each comparison, so both versions began from the same draft.

The main result retains every frozen position, including places where cards might not add a useful next move. This avoids selecting cases based on their outputs, but 49% describes the whole cohort, not a win rate where evidence clearly had an opportunity to help. This cohort did not record that opportunity label for each position before generation, so those two groups cannot yet be separated reliably.

CARD USE · 140/280

Reported card use in continuations with text

The model reports whether a card affected its continuation. In 140 of 280 tests it produced continuation text and reported card use. The previous count of 150 included 10 cases without continuation text and has been corrected.

COMPARISON · 70 / 7 / 30

Which written version was better?

Of the 107 reported-use cases where both versions produced text, the blinded AI judge preferred the with-card version 70 times, found 7 about the same, and preferred the without-card version 30 times.

How are the two table percentages calculated?

ADOPTION COVERAGE

140reported use with text
÷
280all positions
=
50%

WITH-CARD VERSION PREFERRED

70with cards better
÷
107comparable tests
=
65%

The percentages use different groups: 50% counts continuations with text reporting card use among all 280 tests; 65% covers the 107 such cases with text on both sides. The generating model reports card use, while an anonymized AI judge compares writing quality.

Card use is self-reported by the generator. The anonymized AI judge sees the draft and source snippets, so source-aware preference remains possible; there was no independent human review. The overall result describes these 280 frozen positions, not a win probability for any writing task.

Manuscript writing position

Text excerpt · not a PDF page

Research manuscript · excerpt

Large Language Models in Bioinformatics: A Survey

7 Conclusions and Future Directions > 7.2 Future Directions > 7.2.2 Multimodal and Cross-Omics Integration

To overcome the challenges mentioned above, future research should focus on developing efficient, interpretable, and multimodal LLM architectures tailored for bioinformatics.

Integrating LLMs with mechanistic models, represented by graph neural networks (GNNs), and knowledge graphs could improve biological reasoning and interpretability Feng et al. 2025 . Hybrid approaches that combine deep learning with symbolic AI Colelough and Regli 2025 or constraint-based modeling Bystrova et al. 2024 may enable causality-aware predictions in biological systems.

↓ Next paragraph was generated here

The highlighted text is near the writing position. This is a layout of the evaluation input, not a PDF screenshot.

A matched comparison at the same writing positionOverall AI review: Without cards better

Both arms use the same model, task and manuscript context. Only the retrieved passages differ. The first recorded output from each arm is shown below.

Read overall AI review rationale

A = without cards · B = with cards

Both outputs are usable completions, but A better serves the manuscript's argumentative needs. The draft establishes three specific future directions: (1) efficient/interpretable/multimodal LLM architectures for bioinformatics, (2) integrating LLMs with GNNs/knowledge graphs, and (3) hybrid approaches (deep learning + symbolic AI, constraint-based modeling). Output A correctly identifies that the next logical move is to discuss foundational requirements—datasets and evaluation protocols—that would enable these architectural directions, extending the argument without redundancy. Output B, while factually accurate about multi-layer graph representations for cancer subtyping, is more narrowly scoped and somewhat repetitive: the draft already mentions GNN integration and knowledge graphs, and B's focus on cancer molecular subtype classification (from one source) doesn't advance the broader argument about LLM architectures, mechanistic models, and hybrid AI approaches. B also doesn't address the multimodal LLM aspect or the hybrid/symbolic directions raised in the draft. A's discussion of cross-omics transfer evaluation aligns better with the draft's emphasis on improving biological reasoning and interpretability across modalities.

Evidence

Same model and position · retrieved passages supplied · first output

Not preferred in this comparison

Multimodal integration across omics layers is already being pursued through heterogeneous multi-layer graph representations that combine inter-omics and intra-omic connections, as demonstrated by GNN frameworks for cancer molecular subtype classification.

Passages supplied to the Evidence version

Card 1 · Prot2Text: Multimodal Protein’s Function Generation with GNNs and Transformers

In recent years, significant progress has been made in the field of protein function prediction with the development of various machine-learning approaches. However, most existing methods formulate the task as a multi-classification problem, i.e. assigning predefined labels to proteins. In this work…

Read full passage excerpt

In recent years, significant progress has been made in the field of protein function prediction with the development of various machine-learning approaches. However, most existing methods formulate the task as a multi-classification problem, i.e. assigning predefined labels to proteins. In this work, we propose a novel approach, Prot2Text, which predicts a protein's function in a free text style, moving beyond the conventional binary or categorical classifications. By combining Graph Neural Networks(GNNs) and Large Language Models(LLMs), in an encoder-decoder framework, our model effectively integrates diverse data types including protein sequence, structure, and textual annotation and description. This multimodal approach allows for a holistic representation of proteins' functions, enabling the generation of detailed and accurate functional descriptions. To evaluate our model, we extracted a multimodal protein dataset from SwissProt, and demonstrate empirically the effectiveness of Pr …

Card 2 · FluxGAT: Integrating Flux Sampling with Graph Neural Networks for Unbiased Gene Essentiality Classification

Gene essentiality, the necessity of a specific gene for the survival of an organism, is crucial to our understanding of cellular processes and identifying drug targets. Experimental determination of gene essentiality requires large growth screens that are time-consuming and expensive, motivating the…

Read full passage excerpt

Gene essentiality, the necessity of a specific gene for the survival of an organism, is crucial to our understanding of cellular processes and identifying drug targets. Experimental determination of gene essentiality requires large growth screens that are time-consuming and expensive, motivating the development of in-silico approaches. Existing methods predominantly utilise flux balance analysis (FBA), a constraint-based optimisation algorithm; however, they are fundamentally limited by the necessity of a predefined cellular objective function. This requirement introduces an element of observer bias, as the objective function often reflects the researcher's assumptions rather than the cell's biological goals. Here, we present FluxGAT, a graph neural network (GNN) model capable of predicting gene essentiality directly from graphical representations of flux sampling data. Flux sampling removes the need for objective functions, thereby eliminating observer bias. FluxGAT leverages the uniq …

Card 3 · Efficient and Robust Continual Graph Learning for Graph Classification in Biology

Graph classification is essential for understanding complex biological systems, where molecular structures and interactions are naturally represented as graphs. Traditional graph neural networks (GNNs) perform well on static tasks but struggle in dynamic settings due to catastrophic forgetting. We p…

Read full passage excerpt

Graph classification is essential for understanding complex biological systems, where molecular structures and interactions are naturally represented as graphs. Traditional graph neural networks (GNNs) perform well on static tasks but struggle in dynamic settings due to catastrophic forgetting. We present Perturbed and Sparsified Continual Graph Learning (PSCGL), a robust and efficient continual graph learning framework for graph data classification, specifically targeting biological datasets. We introduce a perturbed sampling strategy to identify critical data points that contribute to model learning and a motif-based graph sparsification technique to reduce storage needs while maintaining performance. Additionally, our PSCGL framework inherently defends against graph backdoor attacks, which is crucial for applications in sensitive biological contexts. Extensive experiments on biological datasets demonstrate that PSCGL not only retains knowledge across tasks but also enhances the effi …

Card 4 · A Systematic Review of Deep Graph Neural Networks: Challenges, Classification, Architectures, Applications & Potential Utility in Bioinformatics

In recent years, tasks of machine learning ranging from image processing & audio/video analysis to natural language understanding have been transformed by deep learning. The data content in all these scenarios are expressed via Euclidean space. However, a considerable amount of application data is s…

Read full passage excerpt

In recent years, tasks of machine learning ranging from image processing & audio/video analysis to natural language understanding have been transformed by deep learning. The data content in all these scenarios are expressed via Euclidean space. However, a considerable amount of application data is structured in non-Euclidean space and is expressed as graphs, e.g. dealing with complicated interactions & object interdependencies. Modelling physical systems, learning molecular signatures, identifying protein interactions and predicting diseases involve utilising a model that can adapt from graph data. Graph neural networks (GNNs), specified as artificial-neural models, employ message transmission between graph nodes to represent graph dependencies and are primarily used in the non-Euclidean domain. Variants of GNN like Graph Recurrent Networks (GRN), Graph Auto Encoder (GAE), Graph Convolution Networks (GCN), Graph Adversarial Methods & Graph Reinforcement learning have exhibited breakthr …

Card 5 · A Multimodal Graph Neural Network Framework of Cancer Molecular Subtype Classification

The recent development of high-throughput sequencing creates a large collection of multi-omics data, which enables researchers to better investigate cancer molecular profiles and cancer taxonomy based on molecular subtypes. Integrating multi-omics data has been proven to be effective for building mo…

Read full passage excerpt

The recent development of high-throughput sequencing creates a large collection of multi-omics data, which enables researchers to better investigate cancer molecular profiles and cancer taxonomy based on molecular subtypes. Integrating multi-omics data has been proven to be effective for building more precise classification models. Current multi-omics integrative models mainly use early fusion by concatenation or late fusion based on deep neural networks. Due to the nature of biological systems, graphs are a better representation of bio-medical data. Although few graph neural network (GNN) based multi-omics integrative methods have been proposed, they suffer from three common disadvantages. One is most of them use only one type of connection, either inter-omics or intra-omic connection; second, they only consider one kind of GNN layer, either graph convolution network (GCN) or graph attention network (GAT); and third, most of these methods lack testing on a more complex cancer classifi …

Model-reported card use

Card 5 · fact

Affected output: heterogeneous multi-layer graph representations that combine inter-omics and intra-omic connections

Model explanation: Supplied the concrete mechanism (heterogeneous multi-layer graphs fusing inter-omics and intra-omic connections) used to instantiate the cross-omics integration move.

Card 5 · scope

Affected output: as demonstrated by GNN frameworks for cancer molecular subtype classification

Model explanation: Scoped the claim to a specific attributed prior system (cancer subtype classification) rather than a field-wide trend.

No Evidence

Same model and position · no retrieved passages · first output

Preferred by blind review

Beyond these architectural directions, progress in multimodal and cross-omics integration will depend on the availability of large-scale, well-annotated datasets that align heterogeneous data types, as well as on evaluation protocols that assess whether models transfer across omics layers rather than only within a single modality.

Earlier card-use comparison

The earlier diagnostic compared only cases with reported card use and text on both sides; its scope differs from the overall AI review above.

The blinded model review preferred the Evidence version. Its original rationale appears below.

Read the original model judgment

Output A is grounded in the supplied sources. The claim about 'multimodal integration across omics layers' and 'heterogeneous multi-layer graph representations that combine inter-omics and intra-omic connections' directly reflects the source 'A Multimodal Graph Neural Network Framework of Cancer Molecular Subtype Classification,' which describes exactly this approach. The phrase 'as demonstrated by GNN frameworks for cancer molecular subtype classification' is source-supported. Output B, however, makes unsupported claims about 'the availability of large-scale, well-annotated datasets' and 'evaluation protocols that assess whether models transfer across omics layers rather than only within a single modality.' None of the supplied sources discuss dataset availability challenges, evaluation protocols for cross-omics transfer, or the need for data alignment as a limiting factor. These are plausible-sounding but invented claims about infrastructure and evaluation needs that go beyond what any source states. The sources focus on specific methods (Prot2Text, FluxGAT, PSCGL, cancer subtype classification) and their technical approaches, not on dataset availability or cross-omics transfer evaluation as future directions.

The passages are input material; their presence does not mean an output used them or that they support every claim. Draft and source passages are excerpted; no simulated scores or PDF appear here.